BE
Bonness Enterprises Portfolio holdings
AUM
$305M
1-Year Return
20.16%
This Quarter Return
+1.72%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$144M
AUM Growth
-$3.79M
(-2.6%)
Cap. Flow
-$5.77M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
57.94%
Holding
48
New
1
Increased
–
Reduced
31
Closed
3
Top Buys
| 1 |
BT
BT Group plc (ADR)
BT
|
+$784K |
Top Sells
| 1 |
Stryker
SYK
|
+$756K |
| 2 |
Dell
DELL
|
+$524K |
| 3 |
DXC Technology
DXC
|
+$481K |
| 4 |
Applied Materials
AMAT
|
+$445K |
| 5 |
John Wiley & Sons Class A
WLY
|
+$318K |
Sector Composition
| 1 | Financials | 31.73% |
| 2 | Healthcare | 25.79% |
| 3 | Technology | 20.78% |
| 4 | Industrials | 5.91% |
| 5 | Materials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$146B
| $36.9M | 25.71% |
605,608
-5,000
| -0.8% | -$305K |
|
|
2
Stryker
SYK
$147B
| $11.4M | 7.96% |
71,000
-4,700
| -6% | -$756K |
|
3
Microsoft
MSFT
$3.79T
| $5.18M | 3.61% |
56,700
-1,900
| -3% | -$173K |
|
4
Johnson & Johnson
JNJ
$429B
| $5M | 3.48% |
39,038
-2,000
| -5% | -$256K |
|
5
Intel
INTC
$112B
| $4.69M | 3.26% |
89,950
-1,000
| -1% | -$52.1K |
|
6
DuPont de Nemours
DD
$32.4B
| $4.68M | 3.26% |
36,418
-1,983
| -5% | -$255K |
|
7
IBM
IBM
$236B
| $4.52M | 3.15% |
30,819
| – | – |
|
8
Unilever
UL
$154B
| $3.9M | 2.72% |
70,240
-1,700
| -2% | -$94.5K |
|
9
AbbVie
ABBV
$386B
| $3.47M | 2.41% |
36,600
-1,000
| -3% | -$94.7K |
|
10
Cisco
CSCO
$263B
| $3.42M | 2.38% |
79,700
-1,000
| -1% | -$42.9K |
|
11
Bristol-Myers Squibb
BMY
$94B
| $3.36M | 2.34% |
53,100
-1,000
| -2% | -$63.3K |
|
12
Emerson Electric
EMR
$76B
| $2.97M | 2.07% |
43,500
-1,000
| -2% | -$68.3K |
|
13
Nucor
NUE
$32.4B
| $2.89M | 2.02% |
47,350
-1,000
| -2% | -$61.1K |
|
14
Pfizer
PFE
$136B
| $2.79M | 1.94% |
82,853
| – | – |
|
15
Berkshire Hathaway Class B
BRK.B
$1.07T
| $2.74M | 1.91% |
13,750
| – | – |
|
|
16
Applied Materials
AMAT
$134B
| $2.73M | 1.9% |
49,000
-8,000
| -14% | -$445K |
|
17
Merck
MRK
$207B
| $2.58M | 1.8% |
49,675
-2,096
| -4% | -$109K |
|
18
Thermo Fisher Scientific
TMO
$181B
| $2.37M | 1.65% |
11,500
-1,000
| -8% | -$206K |
|
19
Apple
AAPL
$3.47T
| $2.3M | 1.61% |
54,940
-4,000
| -7% | -$168K |
|
20
GE Aerospace
GE
$299B
| $2.22M | 1.55% |
34,341
| – | – |
|
21
Marsh & McLennan
MMC
$99.8B
| $2.13M | 1.48% |
25,800
-1,000
| -4% | -$82.6K |
|
22
Abbott
ABT
$233B
| $1.96M | 1.36% |
32,700
-2,000
| -6% | -$120K |
|
23
Oracle
ORCL
$830B
| $1.86M | 1.3% |
40,700
| – | – |
|
24
Verizon
VZ
$185B
| $1.76M | 1.23% |
36,887
-1,000
| -3% | -$47.8K |
|
25
Masco
MAS
$15.4B
| $1.72M | 1.2% |
42,500
-6,800
| -14% | -$275K |
|